BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, April 21, 2026
Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Nastech Regains Rights To ED Product Following FTC Ruling

Jan. 28, 2003
By Aaron Lorenzo
Nastech Pharmaceutical Co. Inc. is regaining all rights to a sexual dysfunction product developed for the past year in partnership with Pharmacia Corp., a breakup of sorts brought on by government concerns over a merger between the latter and Pfizer Inc., the maker of Viagra. (BioWorld Today)
Read More

Celator Brings In $6.8M For Work In Combination Chemotherapies

Jan. 27, 2003
By Aaron Lorenzo

Celator Brings In $6.8M For Work In Combination Chemotherapies

Jan. 27, 2003
By Aaron Lorenzo

Antigenics Raises $62M Publicly To Fund Development Programs

Jan. 24, 2003
By Aaron Lorenzo

Antigenics Raises $62M Publicly To Fund Development Programs

Jan. 24, 2003
By Aaron Lorenzo

AtheroGenics Plans Offering Of 6M Shares For Lead Programs

Jan. 22, 2003
By Aaron Lorenzo

AtheroGenics Plans Offering Of 6M Shares For Lead Programs

Jan. 22, 2003
By Aaron Lorenzo

InSite Gets FDA Go-Ahead For Phase III Of ISV-401 Candidate

Jan. 17, 2003
By Aaron Lorenzo

InSite Gets FDA Go-Ahead For Phase III Of ISV-401 Candidate

Jan. 17, 2003
By Aaron Lorenzo

AtheroGenics Starts Pivotal Trial Of AGI-1067 In Atherosclerosis

Jan. 15, 2003
By Aaron Lorenzo
Previous 1 2 … 207 208 209 210 211 212 213 214 215 … 237 238 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 20, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • Novel caspase-2 inhibitor shows in vivo neuroprotective effects

    BioWorld Science
    Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing